Israel Englander Design Therapeutics, Inc. Call Options Transaction History

Millennium Management LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	SELL	$5.5 - $9.77 $195,800 - $347,812	-35,600 Reduced 50.64%	34,700 $200,000
Q4 2022 Feb 14, 2023	BUY	$7.86 - $17.2 $238,158 - $521,160	30,300 Added 75.75%	70,300 $721,000
Q3 2022 Nov 14, 2022	BUY	$14.09 - $25.57 $563,600 - $1.02 Million	40,000 New	40,000 $669,000

102

31M

2.3K

16.5K

Ticker DSGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,807,900
Market Cap $347M
Description
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.